American Century Companies Inc Corcept Therapeutics Inc Transaction History

American Century Companies Inc

  • $167 Billion
  • Q3 2024

A detailed history of American Century Companies Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, American Century Companies Inc holds 97,246 shares of CORT stock, worth $5.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
97,246
Previous 96,735 0.53%
Holding current value
$5.7 Million
Previous $3.14 Million 43.16%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$29.51 - $46.26 $15,079 - $23,638
511 Added 0.53%
97,246 $4.5 Million
Q2 2024

Aug 07, 2024
SELL
$22.21 - $34.48 $1.05 Million - $1.62 Million
-47,088 Reduced 32.74%
96,735 $3.14 Million
Q1 2024

May 14, 2024
BUY
$21.1 - $27.46 $2.2 Million - $2.86 Million
104,114 Added 262.19%
143,823 $3.62 Million
Q4 2023

Feb 13, 2024
BUY
$24.82 - $32.88 $985,577 - $1.31 Million
39,709 New
39,709 $1.29 Million
Q3 2023

Nov 13, 2023
SELL
$21.97 - $33.8 $872,230 - $1.34 Million
-39,701 Reduced 36.78%
68,248 $1.86 Million
Q2 2023

Aug 14, 2023
BUY
$21.44 - $25.15 $273,552 - $320,888
12,759 Added 13.4%
107,949 $2.4 Million
Q1 2023

May 11, 2023
SELL
$19.2 - $24.47 $425,510 - $542,304
-22,162 Reduced 18.89%
95,190 $2.06 Million
Q4 2022

Feb 13, 2023
BUY
$19.95 - $29.96 $309,863 - $465,338
15,532 Added 15.25%
117,352 $2.38 Million
Q3 2022

Nov 14, 2022
BUY
$24.7 - $29.12 $769,997 - $907,786
31,174 Added 44.13%
101,820 $2.61 Million
Q2 2022

Aug 12, 2022
SELL
$17.33 - $25.3 $310,328 - $453,047
-17,907 Reduced 20.22%
70,646 $1.68 Million
Q1 2022

May 11, 2022
BUY
$16.53 - $25.21 $110,486 - $168,503
6,684 Added 8.16%
88,553 $1.99 Million
Q4 2021

Feb 07, 2022
BUY
$17.1 - $23.34 $254,824 - $347,812
14,902 Added 22.25%
81,869 $1.62 Million
Q3 2021

Nov 10, 2021
SELL
$19.68 - $22.53 $1.6 Million - $1.83 Million
-81,164 Reduced 54.79%
66,967 $1.32 Million
Q2 2021

Aug 05, 2021
SELL
$19.97 - $24.43 $183,384 - $224,340
-9,183 Reduced 5.84%
148,131 $3.26 Million
Q1 2021

May 14, 2021
BUY
$23.49 - $30.56 $666,763 - $867,445
28,385 Added 22.02%
157,314 $3.74 Million
Q4 2020

Feb 12, 2021
SELL
$16.78 - $27.3 $463,128 - $753,480
-27,600 Reduced 17.63%
128,929 $3.37 Million
Q3 2020

Nov 13, 2020
BUY
$12.46 - $19.98 $169,144 - $271,228
13,575 Added 9.5%
156,529 $2.72 Million
Q2 2020

Aug 13, 2020
BUY
$11.0 - $18.26 $33,231 - $55,163
3,021 Added 2.16%
142,954 $2.4 Million
Q1 2020

May 14, 2020
BUY
$10.11 - $14.04 $725,655 - $1.01 Million
71,776 Added 105.31%
139,933 $1.66 Million
Q4 2019

Feb 12, 2020
SELL
$12.06 - $16.96 $718,546 - $1.01 Million
-59,581 Reduced 46.64%
68,157 $825,000
Q3 2019

Nov 13, 2019
BUY
$10.41 - $14.66 $151,111 - $212,804
14,516 Added 12.82%
127,738 $1.81 Million
Q1 2019

May 14, 2019
BUY
$10.03 - $15.71 $28,394 - $44,475
2,831 Added 2.56%
113,222 $0
Q4 2018

Feb 13, 2019
SELL
$11.29 - $17.19 $1.58 Million - $2.41 Million
-140,159 Reduced 55.94%
110,391 $1.48 Million
Q3 2018

Nov 02, 2018
BUY
$12.27 - $15.65 $26,429 - $33,710
2,154 Added 0.87%
250,550 $3.51 Million
Q2 2018

Aug 08, 2018
SELL
$15.3 - $19.69 $2.72 Million - $3.5 Million
-177,686 Reduced 41.7%
248,396 $3.91 Million
Q1 2018

May 03, 2018
BUY
$14.59 - $25.5 $7,703 - $13,464
528 Added 0.12%
426,082 $7.01 Million
Q4 2017

Feb 02, 2018
BUY
$15.77 - $20.72 $4.51 Million - $5.93 Million
286,194 Added 205.36%
425,554 $7.69 Million
Q3 2017

Nov 01, 2017
BUY
$12.3 - $19.3 $1.71 Million - $2.69 Million
139,360
139,360 $2.69 Million

Others Institutions Holding CORT

# of Institutions
347
Shares Held
86.6M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.27B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email